Malladi Drugs Pharmaceuticals Limited | CAS 138564-60-0 | Related Intermediates | Manufacturers & Suppliers

Also known as:

Molecular Formula

C₁₂H₁₂ClN₃S

Molecular Weight

265.76 g/mol

InChI Key

FYWKZVBFQWWTHT-UHFFFAOYSA-N

1 2D Structure

CAS 138564-60-0

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-methyl-5H-thieno[3,2-c][1,5]benzodiazepin-4-amine;hydrochloride

2.1.2 InChI

InChI=1S/C12H11N3S.ClH/c1-7-6-8-11(13)14-9-4-2-3-5-10(9)15-12(8)16-7;/h2-6,14H,13H2,1H3;1H

2.1.3 InChI Key

FYWKZVBFQWWTHT-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N.Cl

2.1.5 Isomeric SMILES

CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N.Cl

2.2 Create Date

2006-10-26

3 Chemical and Physical Properties

Molecular Formula	C₁₂H₁₂ClN₃S
Molecular Weight	265.76 g/mol
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	0
Exact Mass	265.0440463 g/mol
Monoisotopic Mass	265.0440463 g/mol
Topological Polar Surface Area	75.7 A^2
Heavy Atom Count	17
Formal Charge	0
Complexity	409
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Malladi Drugs & Pharmaceuticals Lim...

Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.

Contact Supplier

India

Virtual Booth

Digital Content

3-Thiophene Carboxylic Acid-5-Methyl-2-[2(Nitrophenyl)A...

PDF Supplier PDF

URL Supplier Web Content

CAS Number

72242-31-0

End Use API

Olanzapine

About the Company

Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few ...

Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufacturing ephedrine and pseudoephedrine salts. Today, it is the leading manufacturer of APIs in the cough and cold segment. It also has a dominant presence in several therapeutic segments like antihistamines, anti-convulsants, anti-depressants and anxiolytics (CNS). Malladi exports its products to around 60 countries and over 85% of its revenue is generated from exports. Its manufacturing facilities have been approved by the FDA, EDQM, KFDA, TGA and various other regulatory agencies.